Miriam Peregrino-Bazan
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Phase I Trial of Intravenous VCN-01 Oncolytic Adenovirus and Durvalumab in Patients with Head and Neck Metastatic Squamous Cell Carcinoma Refractory to Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 12, 2026
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: March 01, 2022
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects.
Journal: Journal for immunotherapy of cancer
Published: September 11, 2021
Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation.
Journal: Molecular therapy oncolytics
Published: December 18, 2020
Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 30, 2020
Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 16, 2020
Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness.
Journal: International journal of molecular sciences
Published: July 02, 2020
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01.
Journal: Science translational medicine
Published: June 13, 2018
Safety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase expression.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 14, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026